PromptBio

What PromptBio does

PromptBio, Inc. is a privately held, Pleasanton, California-based software company founded in 2023 that builds an AI-native platform for bioinformatics data analysis, omics workflow orchestration, and biomarker discovery. The platform is built around a multi-agent architecture branded PromptGenie, in which DataAgent, OmicsAgent, AnalysisAgent and QAgent collaborate to handle data ingestion, pipeline execution, statistical analysis and interactive summarization; this is complemented by DiscoverFlow for end-to-end multi-omics workflows, ToolsGenie for dynamic generation of executable bioinformatics code, and a set of domain modules (DataGenie for public-database access to SRA and GDC, OmicsGenie for validated pipelines accelerated via NVIDIA Parabricks, MLGenie for automated machine learning on omics features, and MarkerGenie for NLP/LLM-powered literature mining). The supporting infrastructure includes nf-core community pipeline integration, NVIDIA Inception Program membership (April 2024) and Parabricks integration (June 2024), plus an internal PromptBio-Bench evaluation suite of 244 expert-curated tasks.

The commercial model is a three-tier subscription SaaS offering — Pro at $30/month for individuals, Team at $40/seat/month capped at 7 seats, and custom annual Enterprise contracts with SSO, RBAC, LIMS and data lake integration, and SLA-backed reliability — supplemented by usage-based credits for computational overage and a one-month free trial of all Pro features. Go-to-market combines product-led growth through the self-serve platform at platform.promptbio.ai, an enterprise field-sales motion via dedicated business development contacts and demo booking, and event-driven lead generation across BIO International, Precision Health meetings, Multiomics in Precision Medicine, and the Clinical and Translational Omics Symposium.

The customer base is segmented horizontally across individual life-science researchers, small biotech R&D teams, and large pharmaceutical enterprises, with academic users reached through a discount program. Strategic partnerships extend the platform's reach into clinical laboratory services (Eurofins Clinical Enterprise, October 2024) and into African precision medicine via a co-development agreement with South Africa's Council for Scientific and Industrial Research (December 2025). The team of 20+ professionals includes alumni of Illumina, the Broad Institute, Biogen, GRAIL, Caris Life Sciences and MathWorks, and the company has disclosed no funding rounds, revenue figures or ARR to date.

Name

PromptBio

Legal name

PromptBio, Inc.

Website

https://promptbio.ai

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

PromptBio is an AI-powered bioinformatics platform serving life sciences researchers, biotech R&D teams, and pharmaceutical companies with agentic AI workflows for omics data analysis, biomarker discovery, and multi-omics processing.

Ownership category

akta.pro rank

Product category

Bioinformatics Software

NAICS

Software Publishers (51321), Software Publishers (513210)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro industry

PRIMARYHLAGAJAD

Bioinformatics & Multi-omics Analysis Software

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAGAJAO

AI/ML Platforms for Drug Discovery & Experiment Optimization

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHDAAACAD

Prompt Engineering, Orchestration & LLMOps Tooling

Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Foundation Models & Generative AI (LLMs, multimodal)

SECONDARYHDAEANAB

Model Development & Training Platforms (AutoML, Notebooks, Feature Stores)

Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

• Bioinformatics analysis platform
• Multi-omics workflows
• Biomarker discovery software
• AI life sciences
• Agentic AI bioinformatics

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Subscription SaaS - Pro Plan: Monthly subscription at $30/month for individual scientists with routine AI analysis needs. Includes included credits for computational tasks with pay-as-you-go credits available for overage.
2. Subscription SaaS - Team Plan: Per-seat subscription at $40/seat/month for small labs and biotech teams, with maximum 7 seats. Includes shared credit pool across team members and collaborative workspace features.
3. Subscription SaaS - Enterprise Plan: Annual customized subscription plan tailored for large labs and pharmaceutical companies with enterprise-grade deployment, SSO, RBAC, and compliance features.
4. Usage-based Credits: Credits serve as units of compute for actual analysis tasks. Subscription fees include credits with option to purchase additional credits or bulk credit packages for greater flexibility. Billing is based on actual consumption.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

PromptBio develops an Agentic AI-powered software platform that enables life sciences researchers to perform bioinformatics analysis, multi-omics workflows, and biomarker discovery through a conversational natural-language interface. The platform integrates multi-agent AI, GPU-accelerated validated pipelines (NVIDIA Parabricks, nf-core), public database access, automated machine learning, and literature mining, offered through SaaS subscriptions and usage-based compute credits.

Product overview

PromptBio is a modular AI platform for scalable, reproducible, and user-adaptable bioinformatics analysis, powered by generative AI and natural language interaction. The platform comprises three complementary analysis modes: PromptGenie (multi-agent system with DataAgent, OmicsAgent, AnalysisAgent, and QAgent for stepwise workflows), DiscoverFlow (automated workflows for large-scale multi-omics analysis), and ToolsGenie (dynamic code generation for custom analyses). Supporting these are specialized modules including DataGenie (data management and public database integration), MLGenie (automated machine learning for omics), OmicsGenie (validated omics pipelines with NVIDIA Parabricks acceleration), and MarkerGenie (NLP-powered biomedical literature mining). GenAI Agents power conversational automation throughout the platform.

Differentiator

Problem solved

Functional benefit

Brands

• PromptGenie: Multi-agent system enabling stepwise, human-in-the-loop workflows using prevalidated domain-standard tools, including DataAgent, OmicsAgent, AnalysisAgent, and QAgent for data ingestion, pipeline execution, statistical analysis, and interactive summarization.
• DiscoverFlow
• ToolsGenie
• DataGenie
• MLGenie
• OmicsGenie
• MarkerGenie

Products and services

• PromptBio Platform Comprehensive modular AI platform for scalable, reproducible, user-adaptable bioinformatics analysis, powered by generative AI and natural language interaction. Combines three complementary modes (PromptGenie, DiscoverFlow, ToolsGenie) with supporting modules for life sciences researchers, biotech teams, and pharmaceutical R&D.
• PromptGenie A multi-agent system enabling stepwise, human-in-the-loop workflows using prevalidated domain-standard tools. Specialized agents (DataAgent, OmicsAgent, AnalysisAgent, QAgent) collaborate to handle data ingestion, pipeline execution, statistical analysis, and interactive summarization via natural language.
• DiscoverFlow Integrated automated workflows for large-scale multi-omics analysis, providing end-to-end execution and streamlined orchestration for complex research pipelines.
• ToolsGenie Dynamically generates executable bioinformatics code for custom, user-defined analyses, enabling flexibility beyond standardized workflows.
• PromptBio-Bench Evaluation suite of 244 expert-curated tasks spanning bioinformatics and data science at varied difficulty levels, with a framework for structured file comparison and scoring against expert reference answer files.

Quantifiable outcome

• Validated neoantigen prediction pipeline demonstrated efficacy using TESLA benchmark dataset
• +2 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature8 records

Partnerships

Four partnerships are on record, tiered flagship and core.

• CSIR (Council for Scientific and Industrial Research, South Africa)flagshipStrategic or Co-development Partner · 1 December 2025Partnership with South Africa's CSIR to advance AI-powered precision medicine in Africa. This is a significant strategic partnership targeting precision medicine development in the African continent.
• Eurofins Clinical EnterpriseflagshipStrategic or Co-development Partner · 1 October 2024Collaboration with Eurofins Clinical Enterprise to advance generative AI life science applications. Eurofins is a leading laboratory services company, making this partnership significant for clinical and diagnostic applications.
• NVIDIAcoreTechnology or Integration · 1 June 2024PromptBio has integrated NVIDIA Parabricks software into its AI-driven multiomics platform for GPU-accelerated processing. PromptBio joined the NVIDIA Inception Program in April 2024, providing validation of their AI technology and access to NVIDIA's ecosystem.
• nf-corecoreTechnology or Integration · 1 June 2024Platform enables users to run nf-core community pipelines for omics data processing, integrating with this established bioinformatics community standard.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Owkin: Owkin uses AI on patient-level biomedical data to support pharma research and precision medicine. It overlaps with PromptBio's biomarker discovery and multi-omics positioning in translational research.
• Insitro: Insitro applies machine learning to drug discovery using omics and phenotypic data. It is an emerging player with overlapping AI-for-bioinformatics capabilities and a similar target market in pharma R&D.

Direct peers

• Dotmatics: Dotmatics provides a scientific R&D platform spanning biology, chemistry, and data management for life sciences organizations. It overlaps with PromptBio's enterprise positioning around unified research data and analysis workflows.
• DNAnexus: DNAnexus provides a cloud-based genomics and bioinformatics platform used by pharma, clinical labs, and researchers to analyze sequencing and multi-omics data. It is a direct peer in the AI-powered bioinformatics analysis space.
• Benchling: Benchling is a cloud R&D platform for life sciences covering experiment data, molecular biology, and bioprocessing. It directly competes with PromptBio in serving biotech and pharma R&D teams with software to capture, manage, and analyze scientific data.
• Velsera (formerly Seven Bridges): Velsera operates a genomics and clinical data platform for multi-omics analysis and precision medicine. It is directly comparable to PromptBio in offering integrated bioinformatics workflows for pharma and clinical customers.
• Genomenon: Genomenon offers an AI-driven genomic intelligence platform for variant interpretation and biomarker discovery. It is comparable to PromptBio's MarkerGenie and MLGenie capabilities in mining literature and genomics for research insights.

Broad incumbents

• Databricks: Databricks provides a unified data and AI platform widely adopted in life sciences for genomics and biomedical analytics. It competes with PromptBio at the data infrastructure and ML layer for omics use cases.
• Illumina (BaseSpace / ICA): Illumina operates BaseSpace and the Illumina Connected Analytics platform for sequencing data analysis. As the dominant sequencing vendor, it competes with PromptBio on bioinformatics workflows tied to NGS data.
• Palantir (Foundry): Palantir Foundry is used by large pharma (e.g., through deals with the NHS and select biotechs) to integrate biomedical and operational data. It is a broader incumbent competing for enterprise data and AI workloads in life sciences.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/promptbio
• LinkedInlinkedin.com/company/promptbio

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PromptBio